# Keycorp: financial statements, quarterly

KEY · NYSE · CIK 91576 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/key.md) · [Financials](/companies/key/financials.md) · [Filings](/companies/key/filings.md) · [Insiders](/companies/key/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/key/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [347](/filings/0000091576-24-000108.md) | [361 d](/filings/0001628280-26-010546.md) | [399](/filings/0000091576-25-000058.md) | [379](/filings/0000091576-25-000110.md) | [419](/filings/0001628280-25-048757.md) | [448 d](/filings/0001628280-26-010546.md) | [411](/filings/0001628280-26-030507.md) | [425](/filings/0001628280-26-052671.md) | [433](/filings/0001628280-25-048757.md) | [477 d](/filings/0001628280-26-010546.md) | [462](/filings/0001628280-26-030507.md) | [449](/filings/0001628280-26-052671.md) |
| Interest expense | $m | [1,128](/filings/0000091576-23-000125.md) | [1,129 d](/filings/0000091576-24-000040.md) | [1,157](/filings/0000091576-24-000066.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [65.0](/filings/0000091576-24-000108.md) | [(8.0) d](/filings/0001628280-26-010546.md) | [59.0](/filings/0000091576-25-000058.md) | [62.0](/filings/0000091576-25-000110.md) | [(95.0)](/filings/0001628280-25-048757.md) | [(169) d](/filings/0001628280-26-010546.md) | [109](/filings/0001628280-26-030507.md) | [116](/filings/0001628280-26-052671.md) | [112](/filings/0001628280-25-048757.md) | [139 d](/filings/0001628280-26-010546.md) | [136](/filings/0001628280-26-030507.md) | [139](/filings/0001628280-26-052671.md) |
| Net income | $m | [303](/filings/0000091576-24-000108.md) | [65.0 d](/filings/0001628280-26-010546.md) | [219](/filings/0000091576-25-000058.md) | [274](/filings/0000091576-25-000110.md) | [(410)](/filings/0001628280-25-048757.md) | [(244) d](/filings/0001628280-26-010546.md) | [405](/filings/0001628280-26-030507.md) | [425](/filings/0001628280-26-052671.md) | [489](/filings/0001628280-25-048757.md) | [510 d](/filings/0001628280-26-010546.md) | [522](/filings/0001628280-26-030507.md) | [509](/filings/0001628280-26-052671.md) |
| Diluted EPS | $ per share | [0.29](/filings/0000091576-24-000108.md) | not reported | [0.20](/filings/0000091576-25-000058.md) | [0.25](/filings/0000091576-25-000110.md) | [(0.47)](/filings/0001628280-25-048757.md) | not reported | [0.33](/filings/0001628280-26-030507.md) | [0.35](/filings/0001628280-26-052671.md) | [0.41](/filings/0001628280-25-048757.md) | not reported | [0.44](/filings/0001628280-26-030507.md) | [0.44](/filings/0001628280-26-052671.md) |
| Basic EPS | $ per share | [0.29](/filings/0000091576-24-000108.md) | not reported | [0.20](/filings/0000091576-25-000058.md) | [0.25](/filings/0000091576-25-000110.md) | [(0.47)](/filings/0001628280-25-048757.md) | not reported | [0.34](/filings/0001628280-26-030507.md) | [0.35](/filings/0001628280-26-052671.md) | [0.41](/filings/0001628280-25-048757.md) | not reported | [0.45](/filings/0001628280-26-030507.md) | [0.44](/filings/0001628280-26-052671.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [188](/filings/0000091576-23-000125.md) | [188](/filings/0000091576-25-000038.md) | [187](/filings/0000091576-24-000066.md) | [187](/filings/0001628280-24-033136.md) | [190](/filings/0000091576-24-000108.md) | [187](/filings/0001628280-26-010546.md) | [189](/filings/0000091576-25-000058.md) | [185](/filings/0000091576-25-000110.md) | [187](/filings/0001628280-25-048757.md) | [184](/filings/0001628280-26-052671.md) | [189](/filings/0001628280-26-030507.md) | [191](/filings/0001628280-26-052671.md) |
| Total liabilities | $bn | [174](/filings/0000091576-23-000125.md) | [174](/filings/0000091576-25-000038.md) | [173](/filings/0000091576-24-000066.md) | [173](/filings/0001628280-24-033136.md) | [173](/filings/0000091576-24-000108.md) | [169](/filings/0001628280-26-010546.md) | [170](/filings/0000091576-25-000058.md) | [166](/filings/0000091576-25-000110.md) | [167](/filings/0001628280-25-048757.md) | [164](/filings/0001628280-26-052671.md) | [169](/filings/0001628280-26-030507.md) | [172](/filings/0001628280-26-052671.md) |
| Long-term debt | $bn | [21.3](/filings/0000091576-23-000125.md) | [19.6](/filings/0000091576-25-000038.md) | [20.8](/filings/0000091576-24-000066.md) | [16.9](/filings/0001628280-24-033136.md) | [15.7](/filings/0000091576-24-000108.md) | [12.1](/filings/0001628280-26-010546.md) | [12.4](/filings/0000091576-25-000058.md) | [12.1](/filings/0000091576-25-000110.md) | [10.9](/filings/0001628280-25-048757.md) | [9.9](/filings/0001628280-26-052671.md) | [10.9](/filings/0001628280-26-030507.md) | [11.0](/filings/0001628280-26-052671.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [13.4](/filings/0000091576-24-000108.md) | [14.6](/filings/0001628280-26-010546.md) | [14.5](/filings/0000091576-25-000110.md) | [14.8](/filings/0001628280-25-048757.md) | [16.9](/filings/0001628280-25-048757.md) | [18.2](/filings/0001628280-26-052671.md) | [19.0](/filings/0001628280-26-052671.md) | [19.5](/filings/0001628280-26-052671.md) | [20.1](/filings/0001628280-25-048757.md) | [20.4](/filings/0001628280-26-052671.md) | [20.0](/filings/0001628280-26-052671.md) | [19.8](/filings/0001628280-26-052671.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [566 d](/filings/0000091576-24-000108.md) | [1,037 d](/filings/0001628280-26-010546.md) | [359](/filings/0000091576-25-000058.md) | [(217) d](/filings/0000091576-25-000110.md) | [(1,205) d](/filings/0001628280-25-048757.md) | [1,727 d](/filings/0001628280-26-010546.md) | [(140)](/filings/0001628280-26-030507.md) | [1,234 d](/filings/0001628280-26-052671.md) | [396 d](/filings/0001628280-25-048757.md) | [718 d](/filings/0001628280-26-010546.md) | [(62.0)](/filings/0001628280-26-030507.md) | [259 d](/filings/0001628280-26-052671.md) |
| Capital expenditure | $m | [25.0 d](/filings/0000091576-24-000108.md) | [43.0 d](/filings/0001628280-26-010546.md) | [12.0](/filings/0000091576-25-000058.md) | [13.0 d](/filings/0000091576-25-000110.md) | [17.0 d](/filings/0001628280-25-048757.md) | [23.0 d](/filings/0001628280-26-010546.md) | [10.0](/filings/0001628280-26-030507.md) | [23.0 d](/filings/0001628280-26-052671.md) | [29.0 d](/filings/0001628280-25-048757.md) | [45.0 d](/filings/0001628280-26-010546.md) | [12.0](/filings/0001628280-26-030507.md) | [26.0 d](/filings/0001628280-26-052671.md) |
| Dividends paid | $m | [227 d](/filings/0000091576-24-000108.md) | [228 d](/filings/0001628280-26-010546.md) | [229](/filings/0000091576-25-000058.md) | [230 d](/filings/0000091576-25-000110.md) | [230 d](/filings/0001628280-25-048757.md) | [238 d](/filings/0001628280-26-010546.md) | [265](/filings/0001628280-26-030507.md) | [263 d](/filings/0001628280-26-052671.md) | [264 d](/filings/0001628280-25-048757.md) | [262 d](/filings/0001628280-26-010546.md) | [259](/filings/0001628280-26-030507.md) | [258 d](/filings/0001628280-26-052671.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [932](/filings/0000091576-23-000125.md) | [934](/filings/0000091576-24-000066.md) | [930](/filings/0001628280-24-033136.md) | [932](/filings/0000091576-24-000108.md) | [937](/filings/0000091576-25-000058.md) | [938](/filings/0000091576-25-000110.md) | [949](/filings/0001628280-25-048757.md) | [1,106](/filings/0001628280-26-030507.md) | [1,107](/filings/0001628280-26-052671.md) | [1,111](/filings/0001628280-25-048757.md) | [1,094](/filings/0001628280-26-030507.md) | [1,080](/filings/0001628280-26-052671.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,067,128,554 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052671.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.